Alzheimer’s risk may be 35% lower with common menopause treatment, study finds
- Oestrogen-only menopause therapy was linked to lower Alzheimer’s-related risk.
- The Stanford study examined more than 21,000 participants.
- The observational findings do not prove cause and effect.
A Stanford study has found that women who used oestrogen-only menopausal hormone therapy were less likely to show Alzheimer’s-related brain changes or dementia. The findings may add to evidence that hormone treatment could influence brain health after menopause, although they do not establish that the therapy directly prevents…